sFlt-1 binds to and depletes circulating placental growth factor (PlGF) and vascular endothelial growth factor (VEGF), culminating in widespread maternal endothelial dysfunction, systemic vasoconstriction, and the clinical syndrome of PE [21,22]. Here, VEGFA is linked to endothelial dysfunction.